Croda expands lanolin capacity
UK-based supplier of speciality chemicals Croda Oleochemicals, is expanding the group's global manufacturing capacity for lanolin and derivatives. Croda-Westbrook UK production will be consolidated at the company's state-of-the-art plant at Rawcliffe Bridge, East Yorkshire. Manufacturing to GMP standards, the new plant significantly increases production capabilities of material meeting the stringent requirements of pharmaceutical and personal care markets.
Production has also been expanded at Croda's lanolin facility in Brazil.
'This investment provides us with sufficient capacity to satisfy the growing world demand for higher quality products,' said the company.
Meanwhile, Croda Healthcare, the pharma and nutritional division of Croda Oleochemicals, has introduced a new 'smart ingredients package of lipid concentrates for the growing nutraceuticals market. The marine and plant-based omega-3 and -6 polyunsaturated fatty acids provide high levels of DHA (docosahexaenoic acid), EPA (eicosapentaenoic acid) and GLA (gamma-linoleic acid).
Recent studies1 have demonstrated the benefits of DHA, EPA and GLA supplementation for children suffering from ADHD and dyslexia.